Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: An initial experience

Liver International

Volumn 30, Issue 5, 2010, Pages 759-764

  Minami, Yasunori ^a   Kudo, Masatoshi ^a   Hatanaka, Kinuyo ^a   Kitai, Satoshi ^a   Inoue, Tatsuo ^a   Hagiwara, Satoru ^a   Chung, Hobyung ^a   Ueshima, Kazuomi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Contrast harmonic sonography; Hepatocellular carcinoma; Liver metastasis; Perfluorocarbon microbubbles (Sonazoid); Radiofrequency ablation

Indexed keywords

IOMEPROL; PERFLUBUTANE;

ADULT; AGED; ARTICLE; B SCAN; CANCER SIZE; CONTRAST ENHANCED HARMONIC SONOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; RADIOFREQUENCY ABLATION; TREATMENT OUTCOME; TUMOR NECROSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; FERRIC COMPOUNDS; HUMANS; IRON; LIVER NEOPLASMS; MALE; MICROBUBBLES; MIDDLE AGED; OXIDES; PHOSPHOLIPIDS; SULFUR HEXAFLUORIDE;

EID: 77954350631     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02226.x     Document Type: Article

References (31)

1. Rossi S, Di Stasi M, Buscarini E. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am 1995, 1:73-81.
2. Lencioni R, Cioni D, Crocetti L. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005, 234:961-7.
3. Shiina S. Image-guided percutaneous ablation therapies for hepatocellular carcinoma. J Gastroenterol 2009, 44:S122-31.
4. Minami Y, Kudo M, Chung H. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. AJR 2007, 188:489-94.
5. Takayasu K, Muramatsu Y, Asai S, Muramatsu Y, Kobayashi T. CT fluoroscopy-assisted needle puncture and ethanol injection for hepatocellular carcinoma: a preliminary study. AJR 1999, 173:1219-24.
6. Brennan DD, Appelbaum L, Raptopolous V, Kruskal JB, Goldberg SN. CT artifact introduced by radiofrequency ablation. AJR 2006, 186:S284-6.
7. Maeda T, Hong J, Konishi K. Tumor ablation therapy of liver cancers with an open magnetic resonance imaging-based navigation system. Surg Endosc 2009, 23:1048-53.
8. Fujimoto M, Moriyasu F, Nishikawa K, Nada T, Okuma M. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings. AJR 1994, 163:1099-104.
9. Quaia E, D'Onfrio M, Cabassa P. Diagnostic value of hepatocellular nodule vascularity after microbubble injection for characterizing malignancy in patients with cirrhosis. AJR 2007, 189:1474-83.
10. Jang HJ, Kim TK, Burns PN, Wilson SR. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 2007, 244:898-906.
11. Chami L, Lassau N, Malka D. Benefits of contrast-enhanced sonography for the detection of liver lesions: comparison with histologic findings. AJR 2008, 190:683-90.
12. Cioni D, Lencioni R, Bartolozzi C. Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic power Doppler ultrasound. Eur Radiol 2000, 10:1570-5.
13. Meloni MF, Goldberg SN, Livraghi T. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced Power Doppler sonography, and Helical CT. AJR 2001, 177:375-80.
14. Quaia E, Calliada F, Bertolotto M. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004, 232:420-30.
15. Jang HJ, Kim TK, Burns PN, Wilson SR. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 2007, 244:898-906.
16. Wang Z, Tang J, An L. Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma. J Ultrasound Med 2007, 26:757-62.
17. Leen E, Angerson WJ, Yarmenitis S. Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 2002, 41:200-6.
18. Kono Y, Lucidarme O, Choi SH. Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2007, 18:57-65.
19. Ramnarine KV, Kyriakopoulou K, Gordon P. Improved characterisation of focal liver tumours: dynamic power Doppler imaging using NC100100 echo-enhancer. Eur J Ultrasound 2000, 11:95-104.
20. Korenaga K, Korenaga M, Furukawa M, Yamasaki T, Sakaida I. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 2009, 44:733-41.
21. Kudo M. New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma. Hepatol Res 2007, 37:S193-9.
22. Hatanaka K, Kudo M, Minami Y. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008, 51:S61-9.
23. Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H. Phagocytosis of ultrasound contrast microbubbles by Kupffer cells. Ultrasound Med Biol 2007, 33:318-25.
24. Hatanaka K, Kudo M, Minami Y, Maekawa K. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Oncology 2008, 75:S42-7.
25. Numata K, Morimoto M, Ogura T. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J Med Ultrasound 2008, 27:395-406.
26. Maruyama H, Takahashi M, Ishibashi H. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography. Liver Int 2009, 29:708-14.
27. Lim HK, Choi D, Lee WJ. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 2001, 221:447-54.
28. Ramnarine KV, Kyriakopoulou K, Gordon P. Improved characterisation of focal liver tumours: dynamic power Doppler imaging using NC100100 echo-enhancer. Eur J Ultrasound 2000, 11:95-104.
29. Tanimoto A, Yuasa Y, Shinmoto H. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function. Radiology 2002, 222:661-6.
30. Schneider M. Characteristics of SonoVuetrade mark. Echocarciography 1999, 16:743-6.
31. Krasoviski B, Kimmel E. Stability of an encapsulated bubbles shell. Ultrasonics 2006, 44:216-20.